VALBIOTIS news, videos and press releases - Page 4
For more news please use our advanced search feature.
VALBIOTIS - More news...
VALBIOTIS - More news...
- VALBIOTIS Selected at the 80th Scientific Sessions of the American Diabetes Association to Present Phase II Clinical Results of TOTUM-63 in Prediabetes
- VALBIOTIS publishes its annual results for 2019
- VALBIOTIS Accelerates Its Pipeline Clinical Development in New Indications: Cardiovascular and Hepatic Steatosis Risk Reduction
- As Part of a Global Partnership with Nestlé Health Science, VALBIOTIS Initiates the Pivotal Late Stage Development Phase of TOTUM-63, a Plant-Derived Active Substance With Clinically Demonstrated Metabolic Health Benefits in People With Prediabetes
- VALBIOTIS Announces a Global Strategic Partnership With NESTLÉ HEALTH SCIENCE For the Development and Commercialization of TOTUM-63, a Plant-derived Active Substance With Clinically Demonstrated Metabolic Health Benefits on Prediabetics
- VALBIOTIS Presents Positive Results From a Study on TOTUM-63, Active Substance of VALEDIA®, Conducted by the CarMeN Laboratory in Lyon, at the Annual Meeting of the European Association for the Study of Diabetes (EASD)
- VALBIOTIS Announces Additional Positive Results From the Phase IIA Clinical Study of VALEDIA®, the First Product Proven Effective in People With Prediabetes, in Lipid Metabolism and Arterial Hypertension
- VALBIOTIS Strengthens Its Supervisory Board with the Appointment of Agnès TIXIER
- VALBIOTIS Obtains the European Patent for VALEDIA®
